A2M is expensive.
- It has a high PE ratio.
- It has uncertainty regarding CBEC not dispelled, which will perpetuate if not eliminated in the next announcement.
- It has a CEO that sold all of her shares.
- It has many positives in terms of demand for their product, but supply can't meet all the demand.
- It has a growing market share in China and strong Synlait ties
- It has a Fonterra alliance that appears to have delivered very little
- Cash is growing
- Australian competitors are suffering (BAL)
- We know very little about their foray into the USA despite a strong distribution network
The numbers will speak for themselves on AGM day. In my opinion, anything below NZD 350 million in sales will see a major sell off.
Fingers crossed that the numbers are better than what analysts expected.
A2M is expensive. - It has a high PE ratio. - It has uncertainty...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.81 |
Change
-0.090(1.84%) |
Mkt cap ! $3.482B | |||
| Open | High | Low | Value | Volume |
| $4.92 | $4.95 | $4.80 | $8.716M | 1.802M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10795 | $4.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.83 | 5662 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |